Cochrane Abstracts
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antimetabolites as an Adjunct to Dacryocystorhinostomy for Nasolacrimal Duct Obstruction." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Maximal_androgen_blockade_for_advanced_prostate_cancer:_Cochrane_systematic_review. Accessed 30 November 2023.
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Maximal_androgen_blockade_for_advanced_prostate_cancer:_Cochrane_systematic_review. Accessed November 30, 2023.
Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Maximal_androgen_blockade_for_advanced_prostate_cancer:_Cochrane_systematic_review
Antimetabolites as an Adjunct to Dacryocystorhinostomy for Nasolacrimal Duct Obstruction [Internet]. In: Cochrane Abstracts. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Maximal_androgen_blockade_for_advanced_prostate_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction
ID - 432319
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432319/all/Maximal_androgen_blockade_for_advanced_prostate_cancer:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
